Quick Answer: Tirzepatide does not cause high blood pressure and typically reduces both systolic and diastolic blood pressure by 2-8 mmHg through weight loss and improved metabolic function
Because aspiration is a rare event, it may be a long time before we can know with high-quality evidence whether GLP-1 RA use increases aspiration risk
Given that -synuclein aggregation plays such a central role in PD pathology, any intervention that can reduce or prevent this process offers a potential disease-modifying treatment
Lets look at what lipotropic injections are, how they work, and what they do in the body
Increased dose: If side effects such as nausea, fatigue, or digestive issues persist, increase to 2 capsules daily
Its about respecting the science from start to finish